Increased systemic sST2 in patients with end stage renal disease contributes to milder liver damage during HCV infection

Increased systemic sST2 in patients with end stage renal disease contributes to milder liver damage during HCV infection

Introduction: Hepatitis C Virus (HCV) is the leading cause of chronic liver disease and is a serious global health problem. Hepatitis C infection is highly prevalent in patients with end stage renal disease (ESRD), due to frequent exposure to blood and blood products, nosocomial transmission of HCV...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruzica Lukic, Maja Cupic, Nevena Gajovic, Milena Jurisevic, Zeljko Mijailovic, Bojana Davidovic, Bojan Kujundzic, Bojan Joksimovic, Nebojsa Arsenijevic, Ivan Jovanovic
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2020-05-01
Series:Journal of Infection in Developing Countries
Subjects:
HCV
end-stage renal disease
sST2
Online Access:https://jidc.org/index.php/journal/article/view/11741
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jidc.org/index.php/journal/article/view/11741

Similar Items